Al Benson MD

Clinical Trials

• SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed Start of enrollment: 1994 Mar 01

  Completed

  Phase 3

• Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas Start of enrollment: 1998 Jul 01

  Completed

  Phase 3

• Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Start of enrollment: 1998 Oct 01

  Completed

  Phase 3

• Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors Start of enrollment: 1999 Aug 01

  Completed

  Phase 1

• Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors Start of enrollment: 1999 Aug 01

  Completed

  Phase 1

• Combination Chemotherapy in Treating Patients With Advanced Solid Tumors Start of enrollment: 2000 Jan 01

  Completed

  Phase 1

• Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus Start of enrollment: 2000 Feb 01

  Unknown status

  Phase 2

• Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer Start of enrollment: 2003 Oct 15

  Completed

  Phase 3

• Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Start of enrollment: 2005 Sep 06

  ACTIVE_NOT_RECRUITING

  PHASE3

• Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer Start of enrollment: 2006 May 11

  Terminated

  Phase 3

• Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer Start of enrollment: 2010 Jan 18

  Completed

  Phase 2

• Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery Start of enrollment: 2009 Aug 01

  Completed

  Phase 2

• Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28

  Completed

  Phase 3

• Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Start of enrollment: 2011 Jan 18

  Completed

  Phase 2

• Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01

  Active, not recruiting

  Phase 3

• S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01

  Completed

  Phase 2

• A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours Start of enrollment: 2012 Sep 06

  Completed

  Phase 3

• Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors Start of enrollment: 2013 Sep 20

  ACTIVE_NOT_RECRUITING

  PHASE2

• A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma Start of enrollment: 2014 Jul 23

  Terminated

  Phase 2

• FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma Start of enrollment: 2017 Sep 21

  Completed

  Phase 2

• Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma Start of enrollment: 2023 Jul 01

  Recruiting

  Phase 2, Phase 3

  Roles: Contact, Principal Investigator

• Join now to see all